The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksREDX.L Share News (REDX)

  • There is currently no data for REDX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: Tekmar hires former Kromek CFO; Redx chair departs

Tue, 01st Jun 2021 15:51

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Tuesday and not separately reported by Alliance News:

----------

Tekmar Group PLC - provider of technology and services for offshore energy markets - Hires Derek Bulmer as new chief financial officer. Sue Hurst, the current CFO, steps down from the role on Tuesday but will remain on the board for a transition period. Bulmer was CFO and in-house counsel for AIM-listed radiation detection technology firm Kromek Group PLC from 2010 until last year. Prior to Kromek, he had worked at brick maker Ibstock PLC, among other employers. Tekmar also announced its annual results on Tuesday. For the 12 months ended March 31, it swung to pretax loss of GBP2.5 million from a profit of GBP2.0 million the year before, on revenue which declined 29% to GBP29.1 million from GBP40.9 million.

----------

Redx Pharma PLC - Macclesfield, England-based discovery of treatments for cancer and fibrotic disease - Chair Iain Ross steps down as a director immediately "to pursue other business opportunities". Redx makes Independent Non-Executive Director Peter Presland the interim chair as it starts search for new chair. "Iain has been the lynchpin in the turnaround of Redx, and we are very grateful for his innumerable contributions as chairman over the last four years," says Chief Executive Officer Lisa Anson. Ross says he remains "a supportive shareholder".

----------

Chamberlin PLC - West Midlands-based castings and engineering - New CEO Kevin Price and new Finance Director Alan Tomlinson join the board on Tuesday. Non-Executive Director Trevor Brown moves to executive director, responsible for company strategy, effective immediately, while David Flowerday resigns as non-executive director from Monday.

----------

Challenger Energy Group PLC - assets in Bahamas, Uruguay, Trinidad & Tobago and Suriname, previously known as Bahamas Petroleum Co PLC - Eytan Uliel formally takes up role as CEO. Simon Potter steps down as CEO but remains as non-executive director. Stephen Bizzell joins board as non-executive director, replacing Ross McDonald.

----------

Longboat Energy PLC - North Sea-focused exploration and production - Hires Nick Ingrassia as corporate development director. Ingrassia had joined Longboat back in September. Among other roles, he had worked at Faroe Petroleum PLC, whose former management team are behind Longboat Energy. Ingrassia's appointment comes alongside Longboat's announcement on Tuesday of three acquisitions to develop an exploration drilling programme on the Norwegian continental shelf. The acquisitions will be accompanied by a GBP35 million equity raise and are classified as a reverse takeover of Longboat under AIM rules.

----------

Trustpilot AS - Copenhagen-based online consumer reviews platform - Hires Joe Hurd as independent non-executive director. California-based Hurd is an independent public board director and adviser.

----------

India Capital Growth Fund Ltd - invests directly, or indirectly, in companies based in India - Hires Lynne Duquemin as non-executive director, effective immediately, as successor to Peter Niven, who will retire from the board at the end of 2021. Duquemin is a Guernsey resident with "deep experience of investment management and advisory services".

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
19 Apr 2024 16:02

IN BRIEF: Redx Pharma shareholders approve AIM delisting plans

Redx Pharma PLC - clinical-stage biotechnology company - Shareholders pass resolution by 99.75% margin at general meeting to approve cancelling shares on AIM in London. This is now expected to take place on May 1, with last day of trading on April 30. Says it remains the company's intention to provide a matched bargain facility to assist shareholders wishing to trade in shares following the AIM delisting. Says it will make further details available in "due course" on its website.

Read more
12 Apr 2024 15:35

Director dealings: Redx Pharma CEO ups stake

(Sharecast News) - Redx Pharma revealed on Friday that chief executive Lisa Anson had acquired 399,000 ordinary shares in the AIM-listed clinical-stage biopharmaceutical firm.

Read more
2 Apr 2024 16:57

LONDON MARKET CLOSE: Europe down after Easter holiday weekend

(Alliance News) - The FTSE 100 took a hit on Tuesday, after a boost from London's miners and oil firms were not enough to lift the index.

Read more
2 Apr 2024 12:15

Redx Pharma plummets on plans to delist from AIM

(Alliance News) - Redx Pharma PLC shares fell on Tuesday, after it said it intends to cancel its shares from trading on AIM in London.

Read more
2 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe.

Read more
2 Apr 2024 10:50

AIM WINNERS & LOSERS: 88 Energy finds oil at Hickory-1; Redx to delist

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
14 Feb 2024 09:34

IN BRIEF: Redx Pharma clarifies not currently pursuing US listing

Redx Pharma PLC - Macclesfield, England-based clinical-stage biotechnology company - Responds to a Times article published on Tuesday saying RedX is looking to list its shares in New York. Redx says it "wishes to clarify that it is not currently in any process relating to a listing in the US, nor any other jurisdiction".

Read more
7 Feb 2024 11:08

Redx Pharma shares skyrocket on deal to sell inhibitor program

(Alliance News) - Redx Pharma PLC on Wednesday said it has struck a deal to sell Kirsten rat sarcoma virus inhibitor program to Dublin-based Jazz Pharmaceuticals PLC.

Read more
7 Feb 2024 09:29

AIM WINNERS & LOSERS: Verditek falls on cash shell plans

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
15 Dec 2023 21:09

EARNINGS AND TRADING: Redx full year revenue tumbles; loss widens

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
18 Oct 2023 12:30

Redx Pharma looks to progress portfolio after raising GBP14.1 million

(Alliance News) - Redx Pharma PLC on Wednesday said that it has conditionally raised around GBP14.1 million by way of a subscription for 54.1 million shares at 26 pence each.

Read more
21 Aug 2023 10:29

AIM WINNERS & LOSERS: Fulcrum Utility to leave AIM as loss widens

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
21 Aug 2023 09:33

Redx Pharma says RXC007 receives orphan drug designation from US FDA

(Alliance News) - Redx Pharma PLC on Monday said its RXC007 drug has received orphan drug designation from the US Food & Drug Administration for the treatment of idiopathic pulmonary fibrosis, a condition causing breathing difficulty due to lung scarring.

Read more
21 Aug 2023 07:43

LONDON BRIEFING: Crest Nicholson lowers annual profit forecast

(Alliance News) - Stocks in London are called flat on Monday, with little in the way of economic data or company updates to reignite risk appetite.

Read more
10 Jul 2023 11:22

Redx Pharma extends term of outstanding notes with two lenders to 2024

(Alliance News) - Redx Pharma PLC on Monday said it extended the term of its outstanding convertible loan notes issued to two lenders RM Special Holdings 3 LLC, otherwise known as Redmile, and Sofinnova Crossover I SLP by a year.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.